Trigeminal autonomic cephalalgias: beyond the conventional treatments
- PMID: 24974071
- PMCID: PMC4119587
- DOI: 10.1007/s11916-014-0438-z
Trigeminal autonomic cephalalgias: beyond the conventional treatments
Abstract
The trigeminal autonomic cephalalgias include cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks, and hemicrania continua. While the majority responds to conventional pharmacological treatments, a small but significant proportion of patients are intractable to these treatments. In these cases, alternative choices for these patients include oral and injectable drugs, lesional or resectional surgery, and neurostimulation. The evidence base for conventional treatments is limited, and the evidence for those used beyond convention is more so. At present, the most evidence exists for nerve blocks, deep brain stimulation, occipital nerve stimulation, sphenopalatine ganglion stimulation in chronic cluster headache, and microvascular decompression of the trigeminal nerve in short-lasting unilateral neuralgiform headache attacks.
Conflict of interest statement
Dr. Sarah Miller has received educational grants from St Jude Medical, educational and travel grants from Medtronic, and speaker’s fees for Allergen.
Dr. Manjit Matharu serves on the advisory board for Allergan and St Jude Medical, and has received payment for the development of educational material from Allergan, Merck Sharpe, Dohme Ltd, and Medtronic.
References
-
- Pareja JA, Alvarez M. The usual treatment of trigeminal autonomic cephalalgias. Headache. 2013;53:1401–1414. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
